07.08.07 07:18 Age: 3 yrs
Ipsogen expands and opens New Haven office to market its leukaemia molecular diagnostic products in North America
Category: Corporate
Ipsogen, Inc., founded in March 2005 as a subsidiary of Ipsogen SAS, a leading provider of molecular diagnostics in oncology headquartered in Marseille, France, today announced the opening of its new facilities in New Haven, Connecticut, to support the company’s continued growth in North America. The opening of this new office in the George Street Technology Center downtown New Haven, Connecticut, reflects the overall expansion of Ipsogen’ operations, supported by the local fund Connecticut Innovations.
“We’re excited about the expansion of our business in North America. This new office will allow us to handle the continued revenue growth and the increasing number of North American molecular diagnostics laboratories, reference labs and hospitals, using our diagnostic products.” said Stéphane Debono, Ipsogen’s COO.
Ipsogen, Inc. operates now at:
IPSOGEN, Inc.
300 George Street, Suite 315
New Haven, CT 06511,
USA Phone office: (203) 285-6170
Fax: (203) 285-6173
www.ipsogen.com
“Together with the opening of our new US offices, we have hired experienced staff to ensure Ipsogen’s presence both on the West and East US coasts and provide our customers with a stronger commercial and technical support” added Marc Essodaigui, Ipsogen’s Marketing and Sales Director.
Read more
